Literature DB >> 14734206

Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections.

Marcello Ciaccio1, Gabriella Fugardi, Lucina Titone, Amelia Romano, Salvatore Giordano, Giulia Bivona, Francesco Scarlata, Lavinia Vocca, Maria Di Gangi.   

Abstract

BACKGROUND: The flogosis markers currently in use show both low sensitivity and specificity, particularly in neoplastic and degenerative diseases. Procalcitonin (PCT) is a pro-peptide of calcitonin produced mainly but not only in the C-cells of the thyroid glands and, as several studies show, PCT levels in plasma increase during infections. Bacterial infections are also the main cause of death in oncological patients. Furthermore, in patients with leukaemia in chemotherapy recovery, infections often induce relapses. The aim of the present study is to detect PCT levels in plasma in oncohaematologic patients with and without infections.
METHODS: The study was carried out on 54 patients by a quantitative automated immunoassay.
RESULTS: PCT plasma levels > or =0.5 ng were detected in 27 out of 30 patients (90,0%) with bacterial infections; 8 out of 9 patients (88,9%) with viral infections and in 12 out of 15 patients in the control group without statistically significant differences.
CONCLUSIONS: The results, which differ from those in the literature, are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734206     DOI: 10.1016/j.cccn.2003.10.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.

Authors:  L Kitanovski; J Jazbec; S Hojker; M Gubina; M Derganc
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

2.  Clinical Analysis of Severe Radiation Pneumonia.

Authors:  Feng-Jiang Li; Xin Yuan; Cheng Chen; Min-Li Zhu; Chang-Qing Bai; Rui-Juan Wang
Journal:  Int J Gen Med       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.